COVID-19 pneumonia and immune-related pneumonitis: critical issues on differential diagnosis, potential interactions, and management
M Russano, F Citarella, A Napolitano… - Expert opinion on …, 2020 - Taylor & Francis
Introduction The COVID-19 pandemic occurred amid the cancer immunotherapy revolution.
Immune checkpoint inhibitors (ICIs) have become the standard of care for several solid …
Immune checkpoint inhibitors (ICIs) have become the standard of care for several solid …
Differentiation of COVID-19 pneumonitis and ICI induced pneumonitis
DW Dumoulin, HA Gietema, MS Paats… - Frontiers in …, 2020 - frontiersin.org
Immune checkpoint inhibitors (ICI) have become the standard of care treatment for several
tumor types. ICI-induced pneumonitis is a serious complication seen with treatment with …
tumor types. ICI-induced pneumonitis is a serious complication seen with treatment with …
[HTML][HTML] Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment
E Rossi, G Schinzari, G Tortora - Journal for Immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Pneumonitis is a rare but serious adverse event caused by cancer immunotherapy. The
diagnosis between COVID-19-induced pneumonia and immunotherapy-induced …
diagnosis between COVID-19-induced pneumonia and immunotherapy-induced …
Rapidly fatal pneumonitis from immunotherapy and concurrent SARS-CoV-2 infection in a patient with newly diagnosed lung cancer
CM Lovly, KL Boyd, PI Gonzalez-Ericsson, CL Lowe… - MedRxiv, 2020 - medrxiv.org
Immune checkpoint inhibitors (ICIs) are used for the treatment of numerous cancers, but
risks associated with ICI-therapy during the COVID-19 pandemic are poorly understood. We …
risks associated with ICI-therapy during the COVID-19 pandemic are poorly understood. We …
[HTML][HTML] Overlap of immunotherapy-related pneumonitis and COVID-19 pneumonia: diagnostic and vaccine considerations
MB Abid - Journal for Immunotherapy of Cancer, 2021 - ncbi.nlm.nih.gov
The clinically indistinguishable overlap between pneumonitis caused due to immune
checkpoint inhibition (ICI) and pneumonia associated with COVID-19 has posed …
checkpoint inhibition (ICI) and pneumonia associated with COVID-19 has posed …
[HTML][HTML] COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma …
A Dipasquale, P Persico, E Lorenzi… - … for Immunotherapy of …, 2021 - ncbi.nlm.nih.gov
By the beginning of the global pandemic, SARS-CoV-2 infection has dramatically impacted
on oncology daily practice. In the current oncological landscape, where immunotherapy has …
on oncology daily practice. In the current oncological landscape, where immunotherapy has …
[HTML][HTML] Immune-related (IR)-pneumonitis during the COVID-19 pandemic: multidisciplinary recommendations for diagnosis and management
Abstract Immune-related (IR)-pneumonitis is a rare and potentially fatal toxicity of anti-PD (L)
1 immunotherapy. Expert guidelines for the diagnosis and management of IR-pneumonitis …
1 immunotherapy. Expert guidelines for the diagnosis and management of IR-pneumonitis …
[HTML][HTML] COVID-19 and immune checkpoint inhibitors: initial considerations
COVID-19 infections are characterized by inflammation of the lungs and other organs that
ranges from mild and asymptomatic to fulminant and fatal. Patients who are …
ranges from mild and asymptomatic to fulminant and fatal. Patients who are …
Checkpoint inhibitor pneumonitis mimicking COVID-19 infection during the COVID-19 pandemic
As of May 27, 2020, 5,612,601 people have been diagnosed with COVID-19 and 349,060
deaths have been recorded, with a mortality rate of up to 6.22% worldwide. Despite the …
deaths have been recorded, with a mortality rate of up to 6.22% worldwide. Despite the …
Persistent COVID-19 in Immunocompromised Patients–Israeli Society of Infectious Diseases Consensus Statement on Diagnosis and Management
SE Meijer, Y Paran, A Belkin, R Ben-Ami, Y Maor… - Clinical Microbiology …, 2024 - Elsevier
Background Immunocompromised patients with impaired humoral immunity are at risk for
persistent COVID-19 (pCOVID), a protracted symptomatic disease with active viral …
persistent COVID-19 (pCOVID), a protracted symptomatic disease with active viral …
相关搜索
- differential diagnosis covid 19
- covid 19 pandemic
- cancer treatment covid 19
- checkpoint inhibitors covid 19
- critical issues covid 19
- lung cancer covid 19
- use of immunotherapy covid 19
- persistent covid 19
- covid 19 infection
- persistent covid diagnosis and management
- immunocompromised patients diagnosis and management
- multidisciplinary recommendations diagnosis and management
- israeli society diagnosis and management
- consensus statement diagnosis and management
- infectious diseases diagnosis and management
- persistent covid immunocompromised patients